Abd-Elsayed Alaa A, Guirguis Maged, DeWood Mark S, Zaky Sherif S
Department of Anesthesiology, University of Wisconsin School of Medicine and Public Health, Madison, WI.
Department of Anesthesiology, Ochsner Clinic Foundation, New Orleans, LA.
Ochsner J. 2015 Summer;15(2):133-42.
Alpha-2 adrenergic agonists produce safe and effective analgesia, but most investigations studying the analgesic effect of alpha-2 adrenoceptor agonists postoperatively included previous or concomitant administration of other analgesics. Because clonidine potentiates the effect of these drugs, its own intrinsic analgesic effect has been difficult to establish. This study was designed to compare the intraoperative and postoperative effects of epidural clonidine vs bupivacaine for patients undergoing lower abdominal surgery.
This randomized controlled trial included 40 patients aged 18-50 who were scheduled for elective lower abdominal surgery. Patients were randomly divided into 2 groups. Group I (n=20) received epidural clonidine; Group II (n=20) received epidural bupivacaine. Intraoperative and postoperative hemodynamics, pain scores, and complications were monitored.
Mean pain scores were significantly lower in Group I compared to Group II (1.5 ± 0.5 compared to 3.4 ± 1.0, respectively) in the first 12 hours after surgery. Sedation was more prominent in Group I until 9 hours after surgery. Opioid requirements were significantly lower in Group I. Respiratory rate was similar in the 2 groups. Group I had larger decreases from baseline in systolic blood pressure and diastolic blood pressure than Group II. Heart rate in Group I was reduced from baseline, while it was increased in Group II. Less postoperative nausea and vomiting, urinary retention, pruritus, and shivering were observed in Group I.
Compared to bupivacaine, epidural clonidine provided effective intraoperative and postoperative analgesia in selected patients, resulting in a decreased intravenous pain medication requirement and prolonged duration of analgesia after epidural infusion was discontinued.
α-2肾上腺素能激动剂可产生安全有效的镇痛作用,但大多数研究α-2肾上腺素能受体激动剂术后镇痛效果的试验都包括了术前或同时使用其他镇痛药。由于可乐定可增强这些药物的作用,其自身的内在镇痛作用难以确定。本研究旨在比较硬膜外给予可乐定与布比卡因对下腹部手术患者的术中及术后影响。
这项随机对照试验纳入了40例年龄在18至50岁之间、计划接受择期下腹部手术的患者。患者被随机分为两组。第一组(n = 20)接受硬膜外可乐定;第二组(n = 20)接受硬膜外布比卡因。监测术中及术后的血流动力学、疼痛评分和并发症。
术后前12小时,第一组的平均疼痛评分显著低于第二组(分别为1.5±0.5和3.4±1.0)。直到术后9小时,第一组的镇静作用更为明显。第一组的阿片类药物需求量显著更低。两组的呼吸频率相似。第一组的收缩压和舒张压较基线的下降幅度大于第二组。第一组的心率较基线降低,而第二组的心率升高。第一组术后恶心呕吐、尿潴留、瘙痒和寒战的发生率更低。
与布比卡因相比,硬膜外可乐定为特定患者提供了有效的术中及术后镇痛,减少了静脉用镇痛药物的需求,并在硬膜外输注停止后延长了镇痛时间。